BioCentury | Oct 27, 2020
Finance

Tumor profiling play Caris to grow biopharma partnerships with $310M round

...weeks.Wednesday’s round included another $75 million in debt from Sixth Street, and $235 million in equity. Highland Capital Management...
BioCentury | Nov 1, 2010
Finance

IPOs in Sequence

...Health Ventures (19%); Enterprise Partners (14.7%); OVP Venture Partners (14.7%); Prospect Venture Partners (14.1%); and Highland Capital Management...
BioCentury | Aug 23, 2010
Financial News

Complete Genomics completes venture financing

...Investors: Sands Capital; Essex Woodlands Health Ventures; OVP Venture Partners; Prospect Venture Partners; OrbiMed Advisors; Highland Capital Management...
BioCentury | Aug 20, 2010
Financial News

Complete Genomics raises $39 million

...investor Sands Capital. Existing investors Essex Woodlands Health Ventures; OVP; Prospect Venture Partners; OrbiMed Advisors; Highland Capital Management...
BioCentury | Jun 21, 2010
Financial News

Predictive Biosciences completes venture financing

...Date completed: 6/16/10 Type: Venture financing Raised: $25 million Investors: ProQuest Investments; Flybridge Capital Partners; Highland Capital Management...
BioCentury | Sep 7, 2009
Emerging Company Profile

Sequencing by the million: Sidebar: Corporate Profile

...Investors: Prospect Venture Partners; Essex Woodland Health Ventures; OrbiMed Advisors; Enterprise Partners; OVP Venture Partners; Highland Capital Management...
BioCentury | Aug 31, 2009
Financial News

Complete Genomics completes venture financing

...completed: 8/24/09 Type: Venture financing Raised: $45 million Investors: Essex Woodlands Health Ventures; OrbiMed Advisors; Highland Capital Management...
BioCentury | Aug 31, 2009
Finance

Ebb & Flow

...Advisors co-led the D round. Existing investors Enterprise Partners; OVP Venture Partners; Prospect Venture; and Highland Capital Management...
BioCentury | Aug 25, 2009
Top Story

Complete Genomics raises $45 million

...Ventures and OrbiMed Advisors. Existing investors Enterprise Partners; OVP Venture Partners; Prospect Venture Partners; and Highland Capital Management...
Items per page:
1 - 9 of 9
BioCentury | Oct 27, 2020
Finance

Tumor profiling play Caris to grow biopharma partnerships with $310M round

...weeks.Wednesday’s round included another $75 million in debt from Sixth Street, and $235 million in equity. Highland Capital Management...
BioCentury | Nov 1, 2010
Finance

IPOs in Sequence

...Health Ventures (19%); Enterprise Partners (14.7%); OVP Venture Partners (14.7%); Prospect Venture Partners (14.1%); and Highland Capital Management...
BioCentury | Aug 23, 2010
Financial News

Complete Genomics completes venture financing

...Investors: Sands Capital; Essex Woodlands Health Ventures; OVP Venture Partners; Prospect Venture Partners; OrbiMed Advisors; Highland Capital Management...
BioCentury | Aug 20, 2010
Financial News

Complete Genomics raises $39 million

...investor Sands Capital. Existing investors Essex Woodlands Health Ventures; OVP; Prospect Venture Partners; OrbiMed Advisors; Highland Capital Management...
BioCentury | Jun 21, 2010
Financial News

Predictive Biosciences completes venture financing

...Date completed: 6/16/10 Type: Venture financing Raised: $25 million Investors: ProQuest Investments; Flybridge Capital Partners; Highland Capital Management...
BioCentury | Sep 7, 2009
Emerging Company Profile

Sequencing by the million: Sidebar: Corporate Profile

...Investors: Prospect Venture Partners; Essex Woodland Health Ventures; OrbiMed Advisors; Enterprise Partners; OVP Venture Partners; Highland Capital Management...
BioCentury | Aug 31, 2009
Financial News

Complete Genomics completes venture financing

...completed: 8/24/09 Type: Venture financing Raised: $45 million Investors: Essex Woodlands Health Ventures; OrbiMed Advisors; Highland Capital Management...
BioCentury | Aug 31, 2009
Finance

Ebb & Flow

...Advisors co-led the D round. Existing investors Enterprise Partners; OVP Venture Partners; Prospect Venture; and Highland Capital Management...
BioCentury | Aug 25, 2009
Top Story

Complete Genomics raises $45 million

...Ventures and OrbiMed Advisors. Existing investors Enterprise Partners; OVP Venture Partners; Prospect Venture Partners; and Highland Capital Management...
Items per page:
1 - 9 of 9